The Department of Health and Social Care & Medicines and Healthcare products Regulatory Agency, have announced a £10 million investment in the latest medical technology. This funding supports eight tech companies developing devices with the potential to improve outcomes for patients of cancer, Alzheimer’s, stroke and more.
HistoSonics device uses ultrasound waves to target and destroy liver cancer tumors, offering a non-invasive alternative to traditional treatments.
Roche Diagnostics Ltd is introducing a blood test for Alzheimer’s, enabling earlier diagnosis and treatment.
Upfront Diagnostics is rolling out a portable blood test for rapid stroke identification by paramedics, potentially saving thousands from long-term disability.
Lenus Health Ltd.’s wearable AI device supports COPD patients by identifying those individuals that are at greater risk of hospital admissions.
EarSwitch‘s device detects oxygen levels from the inner ear-canal and so offers more accurate oxygen level readings regardless of skin tone.
This investment is part of the Innovative Devices Access Pathway (IDAP) initiative. In collaboration with health organisations, IDAPs aim is to fast-track the development and NHS integration of medical technologies.
Do you sell medical devices in the UK? Medical Devices manufacturers require a UK Authorised Representative to sell in the UK.
EU MDR (Medical Device Regulation)
Comments are closed here.